Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure-activity study

被引:33
作者
Chorell, Erik [1 ,2 ]
Pinkner, Jerome S. [1 ]
Bengtsson, Christoffer [2 ]
Banchelin, Thomas Sainte-Luce [2 ,3 ]
Edvinsson, Sofie [2 ]
Linusson, Anna [2 ]
Hultgren, Scott J. [1 ]
Almqvist, Fredrik [2 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA
[2] Umea Univ, Dept Chem, SE-90187 Umea, Sweden
[3] Umea Univ, Umea Ctr Microbial Res, SE-90187 Umea, Sweden
基金
瑞典研究理事会;
关键词
Pilicide; Antivirulence; 2-Pyridone; Peptidomimetic; Structure-activity; Biofilm inhibitor; RING-FUSED; 2-PYRIDONES; INHIBIT PILUS BIOGENESIS; BIOFILM FORMATION; BICYCLIC; GENETIC-ANALYSIS; REGRESSION; FUNCTIONALIZATION; CLASSIFICATION; INFECTIONS; RESISTANCE;
D O I
10.1016/j.bmc.2012.01.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pilicides prevent pili formation and thereby the development of bacterial biofilms in Escherichia coli. We have performed a comprehensive structure activity relationship (SAR) study of the dihydrothiazolo ring-fused 2-pyridone pilicide central fragment by varying all open positions. Orthogonal projections to latent structures discriminant analysis (OPLS-DA) was used to distinguish active from inactive compounds in which polarity proved to be the most important factor for discrimination. A quantitative SAR (QSAR) partial least squares (PLS) model was calculated on the active compounds for prediction of biofilm inhibition activity. In this model, compounds with high inhibitory activity were generally larger, more lipophilic, more flexible and had a lower HOMO. Overall, this resulted in both highly valuable SAR information and potent inhibitors of type 1 pili dependent biofilm formation. The most potent biofilm inhibitor had an EC50 of 400 nM. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码:3128 / 3142
页数:15
相关论文
共 38 条
[31]   Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli [J].
Schilling, JD ;
Lorenz, RG ;
Hultgren, SJ .
INFECTION AND IMMUNITY, 2002, 70 (12) :7042-7049
[32]   Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection [J].
Snyder, JA ;
Lloyd, AL ;
Lockatell, CV ;
Johnson, DE ;
Mobley, HLT .
INFECTION AND IMMUNITY, 2006, 74 (02) :1387-1393
[33]  
STJOHN RC, 1975, TECHNOMETRICS, V17, P15
[34]   Origins and virulence mechanisms of uropathogenic Escherichia coli [J].
Wiles, Travis J. ;
Kulesus, Richard R. ;
Mulvey, Matthew A. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2008, 85 (01) :11-19
[35]   PRINCIPAL COMPONENT ANALYSIS [J].
WOLD, S ;
ESBENSEN, K ;
GELADI, P .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1987, 2 (1-3) :37-52
[36]   PLS-regression:: a basic tool of chemometrics [J].
Wold, S ;
Sjöström, M ;
Eriksson, L .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2001, 58 (02) :109-130
[37]   THE COLLINEARITY PROBLEM IN LINEAR-REGRESSION - THE PARTIAL LEAST-SQUARES (PLS) APPROACH TO GENERALIZED INVERSES [J].
WOLD, S ;
RUHE, A ;
WOLD, H ;
DUNN, WJ .
SIAM JOURNAL ON SCIENTIFIC AND STATISTICAL COMPUTING, 1984, 5 (03) :735-743
[38]   Biofilm resistance to antimicrobial agents [J].
Xu, KD ;
McFeters, GA ;
Stewart, PS .
MICROBIOLOGY-UK, 2000, 146 :547-549